In diabetes, the glomerular basement membrane undergoes thickening and structural alterations with loss of glomerular permselectivity properties. However, the onset of the alterations at early phases of diabetes is unclear. Aiming to determine the functional and structural alterations of the glomerular wall in the early stages of diabetes, we have studied the distribution of endogenous circulating albumin and type IV collagen in the glomerular basement membrane, using the immunocytochemical approach. The streptozotocin-injected hyperglycemic rat was our animal model. Renal tissues were examined after 10 days, 2, 4 and 6 months of hyperglycemia. Upon immunogold labelings, changes in the glomerular permeability to endogenous albumin were found altered as early as upon ten days of hyperglycemia. In contrast, no structural modifications were detected at this time point. Indeed, glomerular basement membrane thickening and an altered type IV collagen labeling distribution were only observed after four months of hyperglycemia, suggesting that functional alterations take place early in diabetes prior to any structural modification. In order to evaluate the reversibility of the glomerular alterations, two-month-old diabetic animals were treated with insulin. These animals showed a significant restoring of their glomerular permselectivity. Our results suggest a link between glycemic levels and alteration of glomerular permeability in early stages of diabetes, probably through high levels of glycated serum proteins.
INTRODUCTION
The glomerular wall plays an important role in blood filtration. Its properties have been extensively studied by ultrastructural approaches using various circulating endogenous and exogenous markers (Farquhar et al., 1961; Graham and Karnovsky, 1966; Caufield and Farquhar, 1974; Lalibert6 et al., 1978; Bendayan et al., 1986) . Such studies have demonstrated that the transglomerular passage of serum proteins and macromolecules is highly selective. Serum albumin for example, which has a molecular weight of 68 kDa, is normally excluded from transglomerular transport and is not found in *Present address: Anatomo-Pathology, Universidad de Sevilla, Sevilla, Spain. significant amounts in the urine (Bendayan et al., 1986; Pappenheimer, 1953; Brenner et al., 1978a; Ryan and Karnovsky, 1976) . The exclusion of this protein has been considered to be the combined result of size restriction and electrostatic charge repulsion (Brenner et al., 1978) . However, it has been well documented that in diabetic nephropathy, the glomerular permselectivity is markedly impaired, leading to proteinuria (Hostetter, 1986; Viberti et al., 1983) . The loss of glomerular selective permeability occurring in a long-term diabetic condition appears to be concomitant with several other alterations such as increase in glomerular filtration rate (Ditzel and Junker, 1973; Chistiansen et al., 1981) , glycation of circulating proteins (Bunn et al., 1978; Dolholfer and Weiland, 1980; McFarland et al., 1979; Guthrow et al., 1979; Day et al., 1980) and basement membrane components (Cohen et al., 1980; Trueb et al., 1984; Garlick et al., 1988; Bendayan, 1988) , as well as modifications in the structure and composition of the basement membrane (Farquhar et al., 1959; Hirose et al., 1982; Bendayan, 1985; Osterby,1986; Desjardins and Bendayan, 1990; Beisswenger and Spiro, 1970; Pathasarathy and Spiro, 1982; van den Born et al., 1995) . Therefore, associating a single ethiopathological factor to the pathogenesis of glomerular permeability is rather difficult.
Several studies have investigated renal alterations occurring early in diabetes. Renal extracellular matrix gene expression in early stages of experimental diabetes was found to be altered with a marked increase in the mRNAs expression of c chains of type IV procollagen (Wu et al., 1997; Fukui et al., 1992; Yang et al., 1995; Park et al., 1997) and fl chains of laminin (Fukui et al., 1992; Yang et al., 1995) . In addition, increases in expression of the inhibitor of metalloproteinase-1 (Wu et al., 1997) and TGF-fl (Yang et al., 1995; Park et al., 1997) mRNAs have also been reported. In contrast, expression of heparan sulfate proteoglycans (Fukui et al., 1992) and metalloproteinase-2 (Wu et al., 1997) mRNAs seems to undergo decreases. Moriya et al.(1993) (Chiarelli et al., 1997) . Microalbuminuria in early phases of diabetic nephropathy seems to be due to, or is concomitant with, disturbances of the charge barrier of the GBM and is followed by damages to the size restriction barrier (Dechert et al., 1998; Viberti and Wiseman, 1986) . Although streptozotocin-induced-diabetic rats are generally used for the study of the early phases of diabetic nephropathy, timing in the loss of selective permeability properties of the GBM in this experimental model has yet to be determined. The present study was focused on the glomerular wall, assessing its functional and structural features rather than the overall renal function through clearance evaluations which include the tubular reabsorption.
Application of the post-embedding immunogold method on renal tissues allows for the highresolution localization of endogenous albumin within the glomerular wall. This approach was previously applied to the investigation of glomerular permeability in long-term diabetic animals and carries major advantages (Bendayan et al., 1986) . Indeed, the post-embedding approach allows for the detection of serum proteins retained in situ under physiological steady-state conditions. This contrasts with methods using exogenous electron-dense tracers introduced into the circulation with adverse effects on vascular permeability (Cotran and Karnovsky, 1967; Simionescu, 1979; Villaschi et al., 1986) . Furthermore, due to the particulate nature of the colloidal gold marker, morphometric evaluations can be performed assessing the passage of endogenous serum components through vascular walls (Bendayan et al., 1986; Ghitescu and Bendayan, 1992; Bendayan and Rasio, 1996) 6.6+0.35mmol/1 for their age-matched controls (groups 6 to 9) and 4.9+0.8mmol/1 for the insulin-treated streptozotocin-injected animals (group 5). Levels of circulating glycated albumin were measured by radioimmunoassay (Exocell Inc., Philadelphia, PA). Ten days hyperglycemic animals display about 3.5 times more glycated albumin than their age-matched controls (1.46 4-0.07 mg/ml vs. 0.41 4-0.02 mg/ml for the controls), while total serum albumin did not show any significant variation (33.95 4-0.40 mg/ml vs. 36.66 4-3.10 mg/ml for the controls). The hyperglycemic animals also displayed important polyuria with total urine 24h volumes of 1134-13ml (vs. 6.7+1.5ml for the controls). Protein and albumin excretion were of 70.8 4-8.6 mg/24 h and 21.5 4-6.0 mg/24 h respectively (vs. 38.9 4-7.0 mg/24 h and 1.5 4-0.5 mg/24 h for the controls).
Tissue Processing
The animals were anesthetized with urethane and the kidney cortex was immediately fixed in situ by immersion with a periodate-lysineparaformaldehyde solution (McLean et al., 1974) . Small tissue fragments were sampled and maintained in the fixative for two hours at 4C.
They were th rinsed in 0.1mol/1 phosphate (Bendayan, 1995 (Bendayan, 1995 (Fig. 1) . Morphometrical analysis showed that basement membrane thickness of control and hyperglycemic animals at ten days and two months is similar. In contrast, the four-and six-month hyperglycemic animals FIGURE Immuno-electron microscopy of endogenous albumin. (A) Renal tissue of a two-month-old normoglycemic animal. The glomerular wall appears normal with a thin glomerular basement membrane (GBM). The immunolabeling by gold particles, revealing albumin antigenic sites over the GBM, is mainly located over the subendothelial side. Flocculent material present in the capillary lumen (CL) is also labeled. The urinary space (US) as well as podocytes (P) are almost free of labeling; (B) Renal tissue of a two-month old hyperglycemic animal. The glomerular wall shows no significant morphological changes. GBM displays a normal thickness. Gold particles are present over the subendothelial as well as the central and subepithelial side of the GBM; (C) Renal tissue of a two-month-old streptozotocin-injected insulin-treated animal. The labeling by gold particles is located mainly over the subendothelial side of the GBM.
(A x 50 000; B x 44 500; C x 49 000). 
FIGURE 2 Morphometrical analysis of albumin distribution. Distribution of rat albumin immunolabelings in the glomerular basement membrane of normoglycemic and streptozotocininjected hyperglycemic animals as expressed in ratio values R [distance (Endothelium-gold particle)/distance (EndotheliumEpithelium)]. The histograms of all control animals (A,C,E,G) show asymmetrical distributions of the labeling, with peaks in the region corresponding to the subendothelial side of the glomerular basement membrane. For the streptozotocin-injected hyperglycemic animals (B,D,F,H), the distributions of the labeling appear significantly shifted to the right. display significant thickenings with respect to more numerous over the lamina lucida interna the normoglycemic age-matched animals (Tab. (Fig. 1C) FIGURE 3 Morphometrical analysis of albumin distribution. Distribution of rat albumin immunolabeling in the glomerular basement membrane of streptozotocin-injected hyperglycemic animals (3A) and streptozotocin-injected insulin-treated animals (3B) as expressed in ratio values (R). The histogram of the streptozotocin-injected insulin-treated animals (3B) is similar to that of the normoglycemic animals (2C) but differs significantly from that of the age-matched hyperglycemic animals (3A). animals ( Fig. 3B ) was similar to that of the age-matched normoglycemic animals ( Fig. 2C ) and differed significantly from that of the age-matched hyperglycemic animals (p < 0.01) (Fig. 3A) .
The ultrastructural localization of type IVcollagen was also studied on tissues of two-and four-month hyperglycemic and age-matched control animals. Labeling by gold particles was restricted to the extracellular matrix and was absent from the capillary lumina, urinary space and glomerular cells (Fig. 4) . The labeling of the glomerular basement membrane was mainly located over the lamina densa in tissues of twomonth normoglycemic and hyperglycemic animals (Fig. 4) . At four months of hyperglycemia, the labeling was distributed mainly on the subendothelial side of the GBM which indicates FIGURE 4 Immuno-electron microscopy and morphometric analysis of type IV collagen.
Immunolabelings for type IV collagen in the glomerular basement membrane of two-month normoglycemic (A) and two-(B) and four-month (C) streptozotocin-injected hyperglycemic animals. Labeling by gold particles is concentrated on the central lamina densa for the normoglycemic and hyperglycemic animals up to two months. In contrast, tissues from the four-month hyperglycemic animals display significant changes with labelings located towards the subendothelial side of the GBM. The distribution of the labeling, as expressed in ratio (R) values, reported in corresponding histograms, demonstrate significant changes only in tissues of four-month hyperglycemic animals. (A x 39 000 ; B x 32 000; C x 30 000).
an important alteration in the type IV collagen previously reported ones (Bendayan et al., 1986 ; distribution. The morphometrical evaluation re- Ryan and Karnovsky, 1976) . In contrast, in ported in Figure 4 (Bendayan et al., 1986 Schleicher and Olgem611er, 1992) and is (Hardwicke and Squire, 1955) , the morpho-the result of enhanced synthesis and decreased immunocytochemical study allows for the turnover of its structural components (Cohen evaluation Ryan and Karnovsky, 1976) . Streptozotocin-procollagen (Wu et al., 1997; Fukui et al., 1992;  injected hyperglycemic animals displayed the Yang et al., 1995; Park et al., 1997) Suzuki et al., 1997) in the GBM at the early strong proteinuria and major deficiency in phase of diabetes, the accumulation of GBM weight gain. In addition, animals with four or components as early as upon three months of more months of hyperglycemia displayed the diabetes is controversial (Park et al., 1997) . In our renal alterations characteristic of the diabetic study, GBM thickening was observed only after glomerulopathy with thickening of glomerular four months of hyperglycemia. Along with this basement membrane and enlargement of thickening, changes in the distribution of type mesangial matrix (Hostetter, 1986;  Farquhar IV collagen were also observed after four months etal.,1959; Osterby, 1986) .
of hyperglycemia as in long-term diabetes In the normoglycemic animals of all ages, (Bendayan, 1985; Osterby, 1986;  Desjardins and albumin antigenic sites were detected in capil- Bendayan, 1990; Inoue and Bendayan, 1995 (Pathasarathy and Spiro, 1982; van den Born et al., 1995) . Decrease synthesis of glomerular HSPG was previously found in early (Moriya et al., 1993; Rohrbabach et al., 1983) as well as late (Kanwar et al., 1983) stages of experimental diabetes. Therefore, charge barrier alterations could explain the early loss of permselectivity properties of the GBM (Moriya et al., 1993) . On the other hand, physiological factors such as the glomerular plasma flow and filtration rates also affect glomerular function (Hostetter et al., 1981; Anderson and Brenner, 1988) , but their real contribution to the loss of glomerular permselectivity in early stages of diabetes remains, however, uncertain (Castellino et al., 1990) .
Recent studies indicate that alterations in vascular permeability during diabetes could be due to glycation of serum proteins (Williams et al., 1981; Wieland, 1983; Sampietro et al., 1987; Daniels and Hausser, 1992; Sabbatini et al., 1992; Londoo et al., 1995; Bendayan and Londoo, 1996; Cohen and Ziyadeh, 1994) . Amadori products are the predominant forms of circulating glycated proteins in diabetic subjects (Ziyadeh and Cohen, 1993) . Their formation is rapid (Day et al., 1980; Cohen and Ziyadeh, 1994; Higgins and Bunn, 1981) and their half-life short (Shima et al., 1991) . Therefore, levels of Amadori products in serum are directly related to the ambient glucose and are significantly enhanced in diabetic conditions (Neuman et al., 1994; Bakala et al., 1995) . In vitro (Williams et al., 1981; Ghiggeri et al., 1984; Shaklai et al., 1984) and in vivo (Sampietro et al., 1987; Sabbatini et al., 1992; Ghiggeri et al., 1984; Layton and Jerums, 1988) (Londoo et al., 1995; Bendayan and Londoo, 1996) . Alteration of albumin conformation as well as particular interactions with GBM components have been proposed to explain this enhanced glomerular passage of native albumin (Londoo et al., 1995; Ghiggeri et al., 1984;  Layton and Jerums, 1988).
Our present results also show that the altered glomerular albumin distribution in two-month hyperglycemic animals is restored when blood glucose levels are normalized by insulin treatment. This supports the assumption that insulin treatment can restore permselective properties of the GBM. Since Amadori adducts formation is directly related to blood glucose levels (Neuman et al., 1994) , we can assume that insulin treatment, by reducing blood glucose levels, decreases concentrations of circulating Amadori products, thus restoring glomerular function. In conclusion, we propose that circulating glycated albumin, already present as early as upon ten days of hyperglycemia, could enhance glomerular permeability at very early stages and could potentially lead to glomerular injuries.
